Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigenic trigger for type 1 reaction in leprosy.

Robert J Wilkinson1, Diana N J Lockwood

  • 1Division of Medicine, Wellcome Trust Centre for Research Clinical Tropical Medicine, Imperial College London, 2nd Floor Wright Fleming Institute, Norfolk Place, London W2 1PG, UK. r.j.wilkinson@imperial.ac.uk

The Journal of Infection
|March 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profile of bacterial meningitis pathogens circulating in a cohort of school children in Côte d'Ivoire using 16S rRNA gene sequencing.

BMC infectious diseases·2026
Same author

Airway immune signatures of protection and disease progression in recent human tuberculosis household contacts.

Nature immunology·2026
Same author

An update on recent developments in the drug treatment of tuberculous meningitis.

Expert opinion on pharmacotherapy·2026
Same author

Predicting trajectories of illness using RNA velocity of whole blood.

Nature communications·2026
Same author

Contribution of cytotoxic CD8 T cells, neutrophils and type 1 interferon signaling to hyperinflammation in HIV-associated TB meningitis.

bioRxiv : the preprint server for biology·2026
Same author

PET-CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort study.

The Lancet. Respiratory medicine·2026

Leprosy patients undergoing chemotherapy may experience Type 1 reactions. This study suggests that infections by other mycobacteria, not Mycobacterium leprae, might trigger these reactions, offering new insights into leprosy immunology.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Dermatology

Background:

  • Type 1 reactions (reversal or upgrading) affect approximately 10% of leprosy patients post-chemotherapy.
  • The precise immunological triggers for these reactions remain incompletely understood.
  • Previous studies suggest a potential link between Mycobacterium w vaccination and an increased risk of reaction.

Observation:

  • This case study focuses on a patient with borderline lepromatous leprosy.
  • Peripheral blood mononuclear cells were analyzed immediately before and during a Type 1 reaction.
  • The study investigated the antigenic specificity of these cells during the reactional phase.

Findings:

  • The research provides direct evidence supporting the hypothesis that mycobacteria other than Mycobacterium leprae can trigger Type 1 reactions.

Related Experiment Videos

  • Specific antigenic responses were observed in peripheral blood mononuclear cells during the Type 1 reaction.

    • Implications:

    • Findings contribute to a better understanding of the immunological mechanisms underlying leprosy reactions.
    • This knowledge may inform future strategies for managing or preventing Type 1 reactions in leprosy patients.
    • Further research into non-leprae mycobacterial infections could be beneficial for leprosy management.